MSE
GILD icon

MUFG Securities EMEA’s Gilead Sciences GILD Stock Holding History

MUFG Securities EMEA’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-300,000
Closed -$35.1M – 108
2015
Q2 		$35.1M Buy
+300,000
New +$32.8M 5.82% 3
2015
Q1 		– Sell
-200,000
Closed -$18.9M – 101
2014
Q4 		$18.9M Buy
200,000
+50,000
+33% +$5.17M 4.97% 5
2014
Q3 		$16M Buy
+150,000
New +$14.7M 2.38% 8

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

MUFG Securities EMEA's GILD Position: Q1 2026 in Review

MUFG Securities EMEA increased its Gilead Sciences (GILD) stake by 926% in Q1 2026, buying an estimated $66M and bringing the position to 521,862 shares worth $72.7M. The position accounts for 1.09% of the portfolio, ranked #21.

MUFG Securities EMEA first reported a position in GILD in Q4 2013 and has held it in 44 quarters since. The position peaked at $85.5M in Q3 2021. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • MUFG Securities EMEA held 521,862 shares of Gilead Sciences worth $72.7M as of Q1 2026.
  • MUFG Securities EMEA bought 471,000 Gilead Sciences shares in Q1 2026, an estimated $66M.
  • Gilead Sciences made up 1.09% of MUFG Securities EMEA's portfolio in Q1 2026, its #21 holding.
  • MUFG Securities EMEA first reported a position in Gilead Sciences in Q4 2013 and has held it in 44 quarters since.
  • MUFG Securities EMEA's Gilead Sciences position peaked at $85.5M in Q3 2021.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on MUFG Securities EMEA's 13F filing for Q1 2026, filed 11 May 2026.